BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31612394)

  • 1. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.
    Zhu ZZ; Bao LL; Zhao K; Xu Q; Zhu JY; Zhu KX; Wen BJ; Ye YQ; Wan XX; Wang LL; He SQ; Cong WM
    Curr Med Sci; 2019 Oct; 39(5):759-765. PubMed ID: 31612394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma].
    Bao LL; Zhu ZZ; Wen BJ; Wan XX; Ye YQ; Chen L; He SQ; Cong WM
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):349-353. PubMed ID: 28763841
    [No Abstract]   [Full Text] [Related]  

  • 3. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.
    Zhao K; Zhao Y; Zhu JY; Dong H; Cong WM; Yu Y; Wang H; Zhu ZZ; Xu Q
    Curr Med Sci; 2018 Aug; 38(4):590-596. PubMed ID: 30128866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
    Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
    DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.
    Wang D; Zhu ZZ; Jiang H; Zhu J; Cong WM; Wen BJ; He SQ; Liu SF
    Hepatol Int; 2015 Jul; 9(3):438-46. PubMed ID: 26067772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
    Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
    Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
    Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
    Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
    Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
    Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
    Roessler S; Long EL; Budhu A; Chen Y; Zhao X; Ji J; Walker R; Jia HL; Ye QH; Qin LX; Tang ZY; He P; Hunter KW; Thorgeirsson SS; Meltzer PS; Wang XW
    Gastroenterology; 2012 Apr; 142(4):957-966.e12. PubMed ID: 22202459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive and Integrative Analysis Reveals the Diagnostic, Clinicopathological and Prognostic Significance of Polo-Like Kinase 1 in Hepatocellular Carcinoma.
    Lin P; Wen DY; Dang YW; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 47(3):925-947. PubMed ID: 29843122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma.
    Zhou T; Gao Y
    World J Surg Oncol; 2016 Jan; 14(1):8. PubMed ID: 26758762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-490-5p inhibits the metastasis of hepatocellular carcinoma by down-regulating E2F2 and ECT2.
    Fang ZQ; Li MC; Zhang YQ; Liu XG
    J Cell Biochem; 2018 Nov; 119(10):8317-8324. PubMed ID: 29932246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.
    Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN
    Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.